NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Fri, 5 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 4, 2025 Bullish $1.83 V 1
Jun 2, 2025 $1.73 -1.14% $1.76 X 98.30% 0
May 23, 2025 $1.86 +6.05% $1.78 V 95.74% 1
May 23, 2025 $1.68 -3.78% $1.78 X 94.60% 0
May 23, 2025 Bullish $1.78 V 1
May 21, 2025 $1.80 -5.99% $1.76 V 97.69% 1
May 21, 2025 $1.84 -3.75% $1.76 V 95.24% 1
May 21, 2025 $2.51 +37.16% $1.76 X 56.98% 0
Apr 22, 2025 Bullish $3.21 V 1
Apr 10, 2025 $3.14 -3.95% $3.06 V 97.36% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE